EurekAlert (press release)What causes gene transfer to trigger T cell activation and exhaustion? Mary Ann Liebert, Inc./Genetic Engineering NewsEurekAlert (press release)New Rochelle, NY, April 27, 2017–Researchers are beginning to gain a clearer unde… Continue reading
EurekAlert (press release)What causes gene transfer to trigger T cell activation and exhaustion? Mary Ann Liebert, Inc./Genetic Engineering NewsEurekAlert (press release)New Rochelle, NY, April 27, 2017–Researchers are beginning to gain a clearer unde… Continue reading
Boston Business Journal |
CEOs of top gene-editing firms got huge compensation hikes last year
Boston Business Journal It’s no secret that the burgeoning field of gene-editing — a method of cutting out and replacing part of a gene — has generated serious buzz in the biotech world lately. New scientific tools like CRISPR/Cas9 have the potential to revolutionize the … CRISPR Therapeutics and Casebia Therapeutics Announce Exclusive Development and Option Agreement with …GlobeNewswire (press release) CRISPR Therapeutics, Casebia ink AAV deal with StrideBio; Puma gets an AdComm date; Merrimack names new R&D …Endpoints News Crispr Therapeutics AG (CRSP) Given Consensus Recommendation of “Strong Buy” by AnalystsThe Cerbat Gem Sports Perspectives –Benchmark Monitor –Chaffey Breeze all 26 news articles » |
Jewish News |
Stem cell donor pays ‘tiny price to save someone’s life’
Jewish News After further testing, he was told there was a one in four chance of him being able to help an anonymous male patient and last month was confirmed as a definite match. Gould underwent four days of injections to prompt his body to produce more stem cells. |
PLoS Blogs (blog) |
Pulling the Plug on the First Gene Therapy Drug
PLoS Blogs (blog) 2017 is supposed to be the year that FDA finally approves a gene therapy. But last week, the company behind the first approved gene therapy in Europe, uniQure.com, announced that it won’t “pursue the renewal of marketing authorization” that expires … |
STAT |
CRISPR.com was for sale, and you won’t guess who bought it
STAT Though perhaps not as lucrative as the technology itself, the domain could have been advantageous for CRISPR-focused companies — Editas Medicine, CRISPR Therapeutics, Intellia — that might have seen a clever branding opportunity. But until recently … |
STAT |
CRISPR.com was for sale, and you won’t guess who bought it – Stat
STAT The new owner of the prized domain — which had languished in the electronic ether for a decade — is neither Editas Medicine or CRISPR Therapeutics. |